United States Esophagoscopes and Gastroscopes Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Olympus Corporation, FUJIFILM Holdings, Ambu A/S, EvoEndo Inc., EndoMed Systems

Global Esophagoscopes and Gastroscopes Market reached US$1.8 billion in 2024 and is expected to reach US$2.9 billion by 2033, growing at a CAGR of 5.6% during the forecast period 2025-2033

Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/esophagoscopes-and-gastroscopes-market?sg

USA - Industry developments 2025:

✅ 2025-05-01 - Olympus demonstrated its new cloud-based AI endoscopy platform OLYSENSE (CADDIE) at DDW 2025 (AI-assisted detection/characterization apps for GI endoscopy; part of Olympus' push into AI-enabled endoscopy ecosystems).

✅ 2025-05-22 - Olympus announced FDA clearances / market releases in the U.S. in 2025 for its advanced imaging endoscopes (part of EVIS X1 / portfolio updates and related AI/quality-assurance tools). (See Olympus U.S. press list for May-June 2025 items.)

✅ 2025-04-30 - FUJIFILM announced commercialization of the next-generation EG-840T and EG-840TP gastroscopes (800 Series) and showcased them at DDW 2025 - targeted to improve visualization/therapeutic capability in upper-GI procedures (U.S. commercialization activity tied to DDW presence).

Europe - Industry developments 2025:

✅ 2025-05-08 - FUJIFILM Healthcare Europe announced the European launch of ELUXEO® therapeutic gastroscopes EG-840T / EG-840TP (800 Series) - European rollout and product materials were issued in May 2025.

✅ 2025-01-15 - KARL STORZ completed the business transfer of medi-G into the KARL STORZ Group (transaction completed in January 2025) - expansion of KARL STORZ's product/manufacturing footprint in Europe (supports their endoscopy and accessory portfolios).

✅ 2025 (ongoing) - Major European players continue to emphasize AI, imaging upgrades and single-use options for flexible endoscopes in 2025 (EU regulatory rollouts and CE filings for AI tools and new scopes were reported across vendors during 2025 product cycles).

Japan - Industry developments 2025:

✅ 2025-05-01 - Olympus demonstrated AI endoscopy solutions (OLYSENSE/CADDIE) at DDW 2025 - Olympus' AI/diagnostic roadmap (important because Olympus is Japan-headquartered and drives many upper-GI product developments).

✅ 2025-04-30 - FUJIFILM announced the EG-840T / EG-840TP (part of its 800 Series) commercialization activity in 2025 - Fujifilm (Japan) is launching next-gen therapeutic/narrow gastroscopes globally with demonstrations at major conferences.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/esophagoscopes-and-gastroscopes-market?sg

Market growth drivers:

✅ Rising prevalence of gastrointestinal (GI) disorders and cancer-screening demand - increasing incidence of GERD, peptic ulcer disease, gastric cancer and demand for diagnostic upper-GI endoscopies.

✅ Aging populations & preventive screening programs - older demographics in developed markets drive procedure volumes (surveillance, biopsies, early cancer detection).

✅ Technology upgrades & product innovation - transition to high-definition, narrow-band imaging, disposable/single-use endoscopes, and AI-assisted detection improving detection rates and encouraging equipment replacement.

✅ Expanded healthcare infrastructure and favorable reimbursement - investments in hospital/endoscopy suites in emerging markets plus strengthened reimbursement in developed markets increase procedure throughput.

Regional share & dynamics:

➠ North America - largest market (≈30-40% share): strong hospital infrastructure, high procedure rates, favorable reimbursement and early adoption of advanced scopes make North America the largest regional market. (IndustryARC cited ~38% historical share; multiple endoscopy reports confirm North America leads).

➠ Europe - sizable and stable (~20-30%): established screening programs and broad hospital networks keep Europe a major market, with steady replacement demand for HD and therapeutic scopes.

➠ Asia-Pacific - fastest growing (highest CAGR): expanding healthcare capacity, rising GI disease burden, and growing medical device adoption (China, Japan, South Korea, India) drive the strongest regional growth rates. Expect APAC to gain share over the next 5-10 years.

Segments Covered in the Esophagoscopes and Gastroscopes Market:

By Product Type - Esophagoscopes, Gastroscopes

By Usability - Disposable, Reusable

By Application - Esophageal Disorders, Gastric Disorders, Esophageal and Gastric Cancer Detection, Gastric Tissue Biopsy, Esophageal Stent Procedures, Others

By End-User - Hospitals, Specialty Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Others

Regional Analysis for Esophagoscopes and Gastroscopes Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=esophagoscopes-and-gastroscopes-market?sg

Major Key Players: Olympus Corporation, FUJIFILM Holdings Corporation, Ambu A/S, EvoEndo, Inc., EndoMed Systems GmbH, Ottomed Endoscopy, KARL STORZ, Integra LifeSciences Corporation, PENTAX Medical and Erbe Elektromedizin GmbH.

Unlimited Insights. One Subscription: https://www.datamintelligence.com/reports-subscription?sg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.